Acrylamide exposure and incidence of breast cancer among postmenopausal women in the Danish Diet, Cancer and Health Study
暂无分享,去创建一个
Kirsten Frederiksen | Kim Overvad | A. Tjønneland | K. Overvad | K. Frederiksen | A. Olsen | Anne Tjønneland | Anja Olsen | Pelle Thonning Olesen | Henrik Frandsen | H. Frandsen | Pelle Thonning Olesen
[1] C. la Vecchia,et al. Dietary acrylamide and human cancer , 2006, International journal of cancer.
[2] E. Faustman,et al. Formation of N-7-(2-carbamoyl-2-hydroxyethyl)guanine in DNA of the mouse and the rat following intraperitoneal administration of [14C]acrylamide. , 1995, Carcinogenesis.
[3] H. Storm,et al. The Danish Cancer Registry--history, content, quality and use. , 1997, Danish medical bulletin.
[4] John F. Young,et al. Relationships between biomarkers of exposure and toxicokinetics in Fischer 344 rats and B6C3F1 mice administered single doses of acrylamide and glycidamide and multiple doses of acrylamide. , 2006, Toxicology and applied pharmacology.
[5] G. Scherer,et al. Urinary Mercapturic Acids and a Hemoglobin Adduct for the Dosimetry of Acrylamide Exposure in Smokers and Nonsmokers , 2006, Inhalation toxicology.
[6] Gunnar Steineck,et al. Dietary acrylamide and risk of renal cell cancer , 2004, International journal of cancer.
[7] H. Storm,et al. Validity of breast cancer in the Danish Cancer Registry. A study based on clinical records from one county in Denmark , 2002, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[8] M. Törnqvist,et al. Hemoglobin adducts from glycidamide: acetonization of hydrophilic groups for reproducible gas chromatography/tandem mass spectrometric analysis. , 2003, Rapid communications in mass spectrometry : RCM.
[9] L. Hagmar,et al. Differences in hemoglobin adduct levels of acrylamide in the general population with respect to dietary intake, smoking habits and gender. , 2005, Mutation research.
[10] G. Pfeifer,et al. Genotoxicity of acrylamide and glycidamide. , 2004, Journal of the National Cancer Institute.
[11] L. Ehrenberg,et al. The multiplicative model for cancer risk assessment: applicability to acrylamide. , 2001, Carcinogenesis.
[12] S Greenland,et al. Avoiding power loss associated with categorization and ordinal scores in dose-response and trend analysis. , 1995, Epidemiology.
[13] Rodney Snyder,et al. Role of CYP2E1 in the epoxidation of acrylamide to glycidamide and formation of DNA and hemoglobin adducts. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[14] M. Churchwell,et al. Determination of acrylamide and glycidamide serum toxicokinetics in B6C3F1 mice using LC-ES/MS/MS. , 2004, Cancer letters.
[15] E. Bergmark,et al. Hemoglobin adducts of acrylamide and acrylonitrile in laboratory workers, smokers and nonsmokers. , 1997, Chemical research in toxicology.
[16] J. Angerer,et al. Mercapturic acids of acrylamide and glycidamide as biomarkers of the internal exposure to acrylamide in the general population. , 2005, Mutation research.
[17] K. Hashimoto,et al. Biochemical studies on acrylamide, a neurotoxic agent. , 1970, Biochemical pharmacology.
[18] F. Gonzalez,et al. Role of cytochrome P450 2E1 in the metabolism of acrylamide and acrylonitrile in mice. , 1999, Chemical research in toxicology.
[19] G. Becher,et al. Determination and quantification of urinary metabolites after dietary exposure to acrylamide , 2005, Xenobiotica; the fate of foreign compounds in biological systems.
[20] L. Costa,et al. Acrylamide is metabolized to glycidamide in the rat: evidence from hemoglobin adduct formation. , 1990, Chemical research in toxicology.
[21] John F. Young,et al. Toxicokinetics of acrylamide and glycidamide in B6C3F1 mice. , 2005, Toxicology and applied pharmacology.
[22] U. Fuhr,et al. Toxicokinetics of Acrylamide in Humans after Ingestion of a Defined Dose in a Test Meal to Improve Risk Assessment for Acrylamide Carcinogenicity , 2006, Cancer Epidemiology Biomarkers & Prevention.
[23] A. Tjønneland,et al. Study design, exposure variables, and socioeconomic determinants of participation in Diet, Cancer and Health: A population-based prospective cohort study of 57,053 men and women in Denmark , 2007, Scandinavian journal of public health.
[24] J. Angerer,et al. A first approach to estimate the internal exposure to acrylamide in smoking and non-smoking adults from Germany. , 2003, International journal of hygiene and environmental health.
[25] R. L. Prentice,et al. Retrospective studies and failure time models , 1978 .
[26] L. Hagmar,et al. Associations between estimated acrylamide intakes, and hemoglobin AA adducts in a sample from the Malmö Diet and Cancer cohort , 2008, European Journal of Clinical Nutrition.
[27] L. Hagmar,et al. Inconclusive results from an epidemiological study on dietary acrylamide and cancer , 2003, British Journal of Cancer.
[28] J. Angerer,et al. Determination of haemoglobin adducts of acrylamide and glycidamide in smoking and non-smoking persons of the general population. , 2004, International journal of hygiene and environmental health.
[29] H. Adami,et al. Dietary acrylamide and cancer of the large bowel, kidney, and bladder: Absence of an association in a population-based study in Sweden , 2003, British Journal of Cancer.
[30] F. Granath,et al. Who knows whether acrylamide in food is hazardous to humans? , 2003, Journal of the National Cancer Institute.
[31] Keith A. Johnson,et al. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. , 1986, Toxicology and applied pharmacology.
[32] H. Adami,et al. Prospective study of dietary acrylamide and risk of colorectal cancer among women , 2006, International journal of cancer.
[33] M. Haugen,et al. Comparison of estimated dietary intake of acrylamide with hemoglobin adducts of acrylamide and glycidamide. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[34] M. Andersen,et al. Human exposure and internal dose assessments of acrylamide in food. , 2005, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[35] M. Hauptmann,et al. Smoking cigarettes before first childbirth and risk of breast cancer. , 2007, American journal of epidemiology.
[36] James E Klaunig,et al. Acrylamide-induced cellular transformation. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.
[37] M. Beckmann,et al. Influence of Diet on Exposure to Acrylamide – Reflections on the Validity of a Questionnaire , 2005, Annals of Nutrition and Metabolism.
[38] Eden Tareke,et al. Analysis of acrylamide, a carcinogen formed in heated foodstuffs. , 2002, Journal of agricultural and food chemistry.
[39] W. Fritz,et al. WHO‐IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans. Voi. 29: Some Industrial Chemicals and Dyestuffs. 416 Seiten. International Agency for Research on Cancer, Lyon 1982. Preis: 60,‐ sfrs; 30,– US$ , 1983 .
[40] B. Wedzicha,et al. Food chemistry: Acrylamide is formed in the Maillard reaction , 2002, Nature.
[41] P. Inskeep,et al. Comparative tissue distribution and excretion of [1-14C]acrylamide in beagle dogs and miniature pigs. , 1987, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[42] James E Klaunig,et al. Subchronic acrylamide treatment induces a tissue-specific increase in DNA synthesis in the rat. , 2004, Toxicology letters.
[43] S. Greenland. Dose‐Response and Trend Analysis in Epidemiology: Alternatives to Categorical Analysis , 1995, Epidemiology.
[44] M. Törnqvist,et al. Acrylamide: a cooking carcinogen? , 2000, Chemical research in toxicology.
[45] H. Mouridsen,et al. Danish Breast Cancer Cooperative Group (DBCG). Structure and results of the organization. , 1988, Acta oncologica.
[46] H. Tanii,et al. Mutagenicity of acrylamide and its analogues in Salmonella typhimurium. , 1985, Mutation research.
[47] A. Zuckerman,et al. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1995, IARC monographs on the evaluation of carcinogenic risks to humans.
[48] D. E. Carter,et al. Pharmacokinetics of acrylamide in Fisher-344 rats. , 1982, Toxicology and applied pharmacology.
[49] H. Adami,et al. Acrylamide intake and breast cancer risk in Swedish women. , 2005, JAMA.
[50] F. Granath,et al. Health effects of occupational exposure to acrylamide using hemoglobin adducts as biomarkers of internal dose. , 2001, Scandinavian journal of work, environment & health.
[51] H. Mouridsen,et al. Danish Breast Cancer Cooperative Group--DBCG. , 1977, Ugeskrift for laeger.
[52] D. Zyzak,et al. Acrylamide formation mechanism in heated foods. , 2003, Journal of agricultural and food chemistry.
[53] John F. Young,et al. Toxicokinetics of acrylamide and glycidamide in Fischer 344 rats. , 2005, Toxicology and applied pharmacology.
[54] Bahman Asgharian,et al. Acrylamide: a comparison of metabolism and hemoglobin adducts in rodents following dermal, intraperitoneal, oral, or inhalation exposure. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.
[55] M A Stedham,et al. A Lifetime Oncogenicity Study in Rats with Acrylamide , 1995, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[56] M. García-Closas,et al. Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[57] T. Fennell,et al. Metabolism and hemoglobin adduct formation of acrylamide in humans. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[58] G. Pfeifer,et al. A review of mechanisms of acrylamide carcinogenicity. , 2006, Carcinogenesis.